Trinity Legacy Partners »

Vertex Pharmaceuticals Incorporated shares owned by Trinity Legacy Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Trinity Legacy Partners from 13F filings

Historical chart of Trinity Legacy Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Trinity Legacy Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Trinity Legacy Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $275k 658 418.01
2023-12-31 $269k 660 406.89
2023-09-30 $225k 647 347.74
2023-03-31 $206k 654 315.07

More positions owned by Trinity Legacy Partners

Insperity (NSP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
J P Morgan Exchange Traded F Equity Premium (JEPI)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
NVIDIA Corporation (NVDA)
Vanguard World Industrial Etf (VIS)
Main Street Capital Corporation (MAIN)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Apple (AAPL)
Microsoft Corporation (MSFT)
Global X Fds Us Pfd Etf (PFFD)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Caterpillar (CAT)

View all positions for Trinity Legacy Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated